Healthcare & Life Sciences

ILC Therapeutics

alive

About

ILC Therapeutics is a UK-based company that designs and develops engineered hybrid interferons, a novel class of cytokine therapeutics aimed at reducing toxicity and improving efficacy, initially focusing on infectious diseases.

Explore ILC Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.